Lymphoma is a serious cancer of the immune system's lymphatic system, which starts when abnormal lymphocytes (a type of white blood cell) multiply and collect in lymph nodes, impairing the immune ...
The 13th annual Bachelor Auction for Blood Cancer is set to take place on Friday, Oct. 3, 2025, at 6 p.m. at Waxins in Palm Beach Gardens.Stay up to date: The latest headlines and weather from WPBF ...
HOUSTON -- Already indicated for relapsed/refractory follicular lymphoma, the bispecific antibody mosunetuzumab (Lunsumio) showed early promise for improving outcomes in two key lymphoma subtypes, ...
MEDINA COUNTY, Ohio (WOIO) - The Medina County Health Department says there are “elevated” numbers of Hodgkin’s lymphoma among teenagers attending Medina City Schools. After the Medina County Health ...
Being diagnosed with a serious disease like Hodgkin lymphoma is a lot to digest. But once you’ve had time to process your diagnosis, talk will likely turn to the treatments for classic Hodgkin ...
Please provide your email address to receive an email when new articles are posted on . Women who underwent cancer-directed mastectomy with immediate implant-based reconstruction exhibited increased ...
Findings from an FDA general site inspection were enough to delay the approval of odronextamab, as well as other pending applications. The Food and Drug Administration (FDA) has issued another ...
It’s easy to dismiss random, flu-like symptoms as a sign that you’re coming down with something. But when they stick around for weeks and seem to be getting worse, it’s fair to have questions. While ...
Follicular lymphoma -- typically a slow-growing or indolent form of non-Hodgkin lymphoma that arises from B lymphocytes -- accounts for 20% to 30% of all non-Hodgkin lymphoma cases. The indolent ...
CLOVIS, Calif. -- A Clovis woman is facing a life-threatening diagnosis while preparing to welcome new life into the world. Alyssa Kincaid, 27, is five months pregnant and recently learned she has ...
OH, HOW ARE YOU? GOOD. A VERY SPECIAL REUNION HERE AT THE UNIVERSITY OF MARYLAND CHILDREN’S HOSPITAL. OLIVIA HODGKIN’S LYMPHOMA SURVIVOR, RECONNECTED WITH THE TEAM WHO HELPED HER THROUGH HER TREATMENT ...
The FDA has approved Monjuvi (tafasitamab) for relapsed follicular lymphoma, offering hope with improved progression-free survival in combination therapy. Good news for adults battling a specific type ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results